Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer’s disease-Reference-Cited by-同舟云学术

Emerging therapies for treatment of agitation, psychosis, or apathy in Alzheimer’s disease

Published:2024-06-11 Issue: Volume: Page:1-15
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Wang Hui Jue¹²,Chinna-Meyyappan Arun¹²,Feldman Oriel J.¹²,Lanctôt Krista L.¹²³⁴

Affiliation:

1. Neuropsychopharmacology Group, Sunnybrook Research Institute, Toronto, ON, Canada

2. Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada

3. Department of Psychiatry, University of Toronto, Toronto, ON, Canada

4. Department of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Funder

Alzheimer’s Drug Discovery Foundation

Glaxo Wellcome-Sunnybrook Drug Safety Clinic Graduate Student Fellowship

Ontario Graduate Scholarship

Weston Brain Institute

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2024.2363215

Reference111 articles.

1. Neuropsychiatric symptoms in Alzheimer's disease

2. Management of Neuropsychiatric Symptoms of Dementia in Clinical Settings: Recommendations from a Multidisciplinary Expert Panel

3. Prevalence of Neuropsychiatric Symptoms in Dementia and Mild Cognitive Impairment

4. The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis

5. Agitation in cognitive disorders: Progress in the international psychogeriatric association consensus clinical and research definition;Sano M;Int Psychogeriatr,2023

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Commentary on Neuropsychiatric Symptom Profile in Alzheimer's Disease and their Relationship with Functional Decline;The American Journal of Geriatric Psychiatry;2024-07